ICU Equipment

Abiomed is a leading manufacturer of percutaneous mechanical circulatory support systems, headquartered in Danvers, Massachusetts. The company specializes in the Impella family of heart pumps—catheter-based, minimally invasive devices designed to provide hemodynamic support and left ventricular unloading in acute heart failure, cardiogenic shock, and high-risk percutaneous coronary intervention (PCI) settings. Impella represents the world's smallest heart pump technology and is used to facilitate myocardial recovery and protect native heart function during complex cardiac procedures. The company's product portfolio includes multiple Impella configurations targeting different clinical scenarios, from acute myocardial infarction and cardiogenic shock to elective protected PCI in patients with severe coronary artery disease or advanced heart failure. Abiomed provides comprehensive clinical support services including on-site, on-call, and online technical and clinical assistance to healthcare professionals. The company maintains a global footprint with major operational centers in the United States (Danvers, Woburn, Baltimore), Europe (Aachen, Berlin), and Japan. Abiomed is a Johnson & Johnson MedTech company and operates within the cardiac support and interventional cardiology market. Clinical evidence demonstrates long-term survival benefits and myocardial recovery outcomes associated with Impella-supported procedures, supported by randomized controlled trials and registry data presented at major cardiology conferences.

Vantive is an independent healthcare company specializing in vital organ therapies, with a 70-year legacy in kidney care products and services. The company develops and markets dialysis equipment, continuous renal replacement therapy (CRRT) systems, and extracorporeal carbon dioxide removal (ECCO2R) technology for acute care settings. Vantive's product portfolio includes peritoneal dialysis systems such as HomeChoice, hemodialysis platforms, and advanced therapies like PrismaLung+ for ARDS management. The company serves chronic kidney disease patients and acute care settings through three integrated pillars: therapies (innovative medical devices for kidney and organ support), digital solutions (software platforms to optimize care quality and efficiency), and advanced services and education (clinician training and patient support programs). Vantive operates across home-based therapies, in-center dialysis, and acute care markets. The company emphasizes coordinated care ecosystems and patient-centric treatment options including home dialysis modalities. Manufacturing and R&D capabilities support clinical research and regulatory submissions. Vantive prioritizes evidence-based innovation with publications in peer-reviewed journals and presentations at major nephrology conferences. The organization serves patients, caregivers, and clinical teams with comprehensive support resources and medical information services.

Medical Solutions, Inc. manufactures patient warming and fluid management systems for operating rooms, intensive care units, and emergency departments. The company specializes in perioperative and critical care thermal management solutions, including forced-air convective warming systems, intravenous fluid warmers, and rapid infusion devices. Product lines include the Cocoon™ forced-air warming system, fluid warming systems for hypothermia prevention, and the ThermaCor® 1200 rapid infuser for controlled fluid administration. These devices are designed to maintain normothermia during surgery and critical care interventions, reducing complications associated with inadvertent perioperative hypothermia. The company provides full technical support, service and quality assurance capabilities, and maintains dedicated sales and customer service operations. MSI serves hospital operating rooms, ICUs, and trauma centers across the United States.

Medasense Biometrics Ltd. is an Israel-based medtech company specializing in AI-driven nociception monitoring to quantify pain response and optimize analgesia in clinical settings. The company's proprietary NOL® technology analyzes physiological signals to help clinicians personalize pain treatment, reduce opioid use, and prevent postoperative pain. The FDA-authorized PMD-200™ platform is designed for critical care applications including anesthesia and surgery, providing real-time visualization of patient pain levels. Medasense's pipeline includes NOLedge™, which extends pain insights to clinic and home care settings. The company addresses the global pain management crisis through non-invasive quantification of pain responses, supporting healthcare providers with clinical evidence, education via Medasense Academy, and collaborations with major OEMs including Medtronic, Philips, Mindray, and Nihon Kohden. Applications span intraoperative monitoring, postoperative pain prevention, and emergency care settings.

Puerto Rico Hospital Supply Inc. is a leading medical supplies manufacturer and distributor based in Rio Grande, Puerto Rico, serving the region since 1946. Operating from a state-of-the-art 100,000+ sq. ft. facility with offices, warehouse, and distribution center, the company provides comprehensive healthcare solutions to hospitals, clinics, and healthcare facilities. Their product portfolio includes surgical supplies, patient monitoring equipment, and specialty furniture designed to support operational efficiency across various healthcare settings. As a trusted regional partner, they combine quality assurance with healthcare expertise to deliver essential medical products and logistics support for healthcare providers throughout Puerto Rico and the Caribbean.

Maveric Medical is a medical device sales, marketing, and manufacturing company specializing in laboratory, acute care, and post-acute care solutions. Since 2015, the company has built a reputation for bringing innovative technologies to market through strong relationships across the healthcare industry and deep understanding of medical distribution channels. Their product portfolio focuses on blood collection and leukocyte reduction systems, serving hospitals and healthcare facilities with high-quality, competitively positioned medical devices. The company leverages over 20 years of combined experience in medical distribution and manufacturing, enabling rapid market entry and reliable product performance.

Pharaoh Neuro, Inc. develops the Neurapheresis™ platform, an investigational extracorporeal cerebrospinal fluid (CSF) filtration therapy designed to remove foreign constituents, pathogens, and blood degradation products from the CSF in neurocritical patients. The company, founded in 2017 as a collaboration between Minnetronix Neuro and Duke University Medical Center, focuses on restoring CSF balance to protect brain health and improve outcomes in patients with acute neurological conditions. Current clinical initiatives include subarachnoid hemorrhage (SAH), cryptococcal meningitis, and leptomeningeal carcinomatosis. The Neurapheresis™ system operates via spinal catheter extension, offering precision management of intracranial pressure and metabolic waste clearance in the neurocritical care setting. The device is currently in clinical investigation under FDA Investigational Device Exemption (IDE) and has not yet received FDA clearance or approval for commercial distribution in the United States.

TransMedics Group, Inc. is a medical technology company headquartered in Andover, Massachusetts, specializing in organ preservation and transplantation. The company manufactures the Organ Care System (OCS)—an FDA-approved, portable ex vivo perfusion platform that maintains donor organs in a near-physiologic state outside the body. TransMedics offers specialized OCS systems for lung, heart, and liver transplantation, addressing critical limitations of traditional cold storage by reducing ischemic injury, improving organ viability assessment, and enabling long-distance organ retrieval. The company also operates the National OCS Program (NOP), providing comprehensive end-to-end technology and clinical support services to transplant centers, including organ procurement logistics, clinical expertise, and resource optimization. Founded in 1998, TransMedics went public in 2019 and has established itself as a leader in transforming transplant outcomes for patients with end-stage organ failure.

MediPines Corporation develops the AGM100®, a non-invasive, point-of-care device for rapid assessment of cardiorespiratory function and pulmonary gas exchange. The AGM100 delivers oxygenation, ventilation, and gas exchange measurements in under 2 minutes with accuracy comparable to arterial blood gas analysis. Designed for emergency departments and acute care settings, it enables clinicians to quickly identify respiratory impairment severity and gas exchange abnormalities in patients presenting with dyspnea, chest pain, or undifferentiated respiratory distress. The device addresses critical diagnostic gaps in conditions such as COPD exacerbation, pneumonia, heart failure, pulmonary embolism, and acute asthma. FDA 510(k) cleared and newly reimbursable under dedicated CPT code, the AGM100 improves diagnostic efficiency, reduces unnecessary serial testing and observation admissions, and supports evidence-based treatment decisions at the point of care.

Trivitron Healthcare is a Chennai-based private medical technology company established in 1997, operating across 180+ countries with 15 USFDA- and CE-certified manufacturing facilities. The company specializes in integrated healthcare solutions spanning medical imaging, in-vitro diagnostics (IVD), newborn screening, radiation protection, critical care equipment, renal care solutions, and operating room systems. Trivitron delivers comprehensive turnkey healthcare solutions including facility design, equipment procurement, installation, and ongoing maintenance support. The company operates modern laboratory platforms for high-throughput automated diagnostics, portable screening systems for early disease detection in resource-limited settings, patient monitoring and ventilation systems for ICU environments, and AI-enhanced imaging analytics. With over 100,000 customers including hospitals, clinics, and laboratories globally, Trivitron focuses on making quality healthcare accessible and affordable in underserved regions, particularly across Africa and developing economies.

The SideLyer is an innovative motorized repositioning system designed to prevent pressure injuries, enhance patient mobility, and reduce physical strain on caregivers. With over 25 years of proven performance, the SideLyer features a durable steel frame, waterproof padded mattress, motorized multi-directional positioning (side, back, angled), and full-access controller for easy operation. The system includes quick-release multi-directional caster wheels, attachable IV pole, and pull-out trays for medical settings. Clinical evidence demonstrates a 10-fold reduction in pressure ulcer incidence and 28% lower staff injury claim costs. Trusted by hospitals, nursing homes, skilled nursing facilities, intermediate care facilities (ICF/IID), rehabilitation centers, hospice, and home health settings. Serves patients with complex medical needs, developmental disabilities, and individuals at high risk of pressure ulcers. 93% of healthcare professionals recommend SideLyer for at-risk populations.

Centese is a medical technology company specializing in intelligent digital solutions for post-operative surgical drainage in cardiothoracic surgery. Founded in 2015 and based in Omaha, Nebraska, Centese develops FDA-cleared systems that enhance patient safety and clinical decision-making following cardiac and thoracic procedures. The company's flagship product, Thoraguard, is an automated chest tube management system that addresses critical challenges in post-operative recovery, including drainage complications, extended hospital stays, and labor-intensive nursing workflows. Thoraguard delivers real-time monitoring of drainage volume and air leak rates with 24-hour trend analysis, features the first and only automated clog clearance system for chest tubes, and provides digital alerts for unexpected disruptions. The system is designed as a compact, all-in-one platform for both cardiac and thoracic surgical populations. Centese has treated nearly 15,000 patients and is expanding across U.S. hospitals with plans to enter the European market.

Securisyn Medical develops innovative airway management and securement devices designed to enhance airway safety, prevent unplanned extubation, and reduce associated clinical complications. The company's core focus is on endotracheal tube stabilization solutions for both adult and pediatric populations, including neonatal applications. Their flagship product, SolidAIRity® Flex, targets adult airway securement with applications across ICU, operating room, and field trauma environments. Securisyn's approach emphasizes patient safety, practitioner confidence, and healthcare cost reduction through evidence-based device design and clinical validation. The company is committed to sustainable, ethical business practices while advancing ventilator safety standards and airway management protocols across acute care settings.

AlgoDx AB is a Stockholm-based healthcare AI company founded in 2018 that develops clinically validated machine learning algorithms for sepsis management and clinical decision support in intensive care settings. The platform integrates with electronic health records (EHR) to analyze patient data in real time, flagging rising sepsis risk and automating CMS SEP-1 bundle compliance. AlgoDx delivers actionable insights directly at the point of care through instant notifications to healthcare professionals, reducing diagnostic delays and improving patient outcomes while minimizing documentation burden. The solution supports seamless EHR integration, predictive analytics for early sepsis detection, and automatic clinical guideline compliance—helping hospitals optimize both clinical results and financial performance in critical care environments.

Berlin Heart Inc. is a US-based medical device manufacturer specializing in ventricular assist devices (VADs) for mechanical circulatory support in pediatric and adult populations. Founded in 2005 as the North American subsidiary of Berlin Heart GmbH, the company develops and markets innovative extracorporeal circulatory support systems designed to bridge pediatric and neonatal patients awaiting heart transplantation or to support recovery from acute heart failure. The flagship EXCOR® Pediatric system has demonstrated clinical reliability with use in over 2,300 pediatric patients worldwide and is FDA-approved for use across US implanting centers. Berlin Heart maintains strategic partnerships with leading cardiac centers throughout North America and provides comprehensive clinical support services including anticoagulation management, training, and outcomes documentation through the ACTION Network collaborative initiative.

Synapse Biomedical Inc. is an FDA-approved medical device company specializing in neurostimulation products for treating chronic respiratory insufficiency. Founded in 2002 and based in Oberlin, Ohio, the company develops minimally invasive diaphragm pacing systems designed to reduce mechanical ventilator dependence in patients with spinal cord injuries, amyotrophic lateral sclerosis (ALS), and other neurological conditions. The company's flagship product, the NeuRx® Diaphragm Pacing System (DPS), electrically stimulates the diaphragm to assist ventilation and restore respiratory muscle function. With over 2,000 patients successfully treated and coverage by Medicare, Medicaid, and private insurance, Synapse continues to advance respiratory care standards. The company also offers the TransAeris® system for preventing ventilator-induced diaphragm dysfunction (VIDD) in critically ill patients requiring temporary stimulation.

Manatec SARL manufactures the Eastern Rail System, a healthcare mounting solution designed for critical care environments. The system provides nursing personnel with a simple, reliable method to mount critical care and support equipment near patients while keeping equipment off the floor. The company's Mobile Acute Care System (MACS) solution is built to rapidly expand patient care capacity and clinical capabilities. Manatec focuses on innovative, tailor-made mounting and infrastructure solutions for acute care settings, with emphasis on reliability, quality service, and customer relationships.

RehabMart is a B2B/B2C e-commerce platform specializing in adaptive equipment, assistive devices, and rehabilitation products for individuals with disabilities, special needs, and medical conditions. Founded nearly 20 years ago by a Pediatric Occupational Therapist and operated by occupational and physical therapy professionals, the company supplies healthcare facilities, rehabilitation clinics, schools, home health organizations, VA, and individual caregivers. Product portfolio includes patient lifts (standing, Hoyer, specialty), mobility aids (wheelchairs, walkers, rollators), hospital beds, wheelchair cushions and ramps, bathroom safety equipment (bath lifts, shower chairs), physical therapy devices (parallel bars, mat tables, continuous passive motion machines), oxygen delivery systems (concentrators, CPAP), gait trainers, therapeutic ultrasound, cryotherapy, lymphedema pumps, special needs protective helmets, seating systems, and daily living aids. Offers installation, service, and repair support; financing options; and curated product collections for veterans, schools, and builders.

Atlas Mobility (formerly Atlas Lift Tech) is a technology-enabled mobility services provider serving hospitals across the United States. Founded in 2009 and headquartered in San Ramon, CA, the company specializes in Safe Patient Handling and Mobility (SPHM), hospital-acquired pressure injury (HAPI) prevention, and intra-hospital patient transport. Atlas delivers a comprehensive Total Mobility Solution combining onsite Mobility Technicians (available up to 24/7), proprietary Atlas Mobility Cloud software for real-time monitoring and protocol compliance tracking, dedicated Program Managers, and SPHM training and guideline implementation. The company has demonstrated measurable outcomes across 60+ facilities: 32% reduction in hospital-acquired pressure injuries, 22% decrease in patient falls, 39% lower SPHM-related injury costs, and average facility savings of $162k annually in training cost avoidance. Atlas addresses critical hospital challenges including nursing shortages, patient deconditioning from immobility, and caregiver safety—reducing staff injuries and turnover while improving patient outcomes and length of stay. The company is certified as a Great Place to Work.

Baitella AG, operating as FISSO, is a Swiss precision mechanics manufacturer founded in 1958 and headquartered in Zurich. The company specializes in user-friendly, customizable articulated arms with central clamping units, designed for both medical and industrial applications. With ISO 9001 and ISO 13485 certifications since 1997, FISSO produces all products in Switzerland, emphasizing "Swiss Made" quality and reliability. In medical settings, FISSO systems serve surgical and intensive care applications including ventilation system support, patient positioning, endoscope holders, and retractor holders. Industrial applications include runout testers, probe holders, and indicator stands. The company offers OEM customization, quick-release systems, and maintenance-free operation with high adaptability. FISSO maintains worldwide distribution and has recently established FISSO USA Inc. to strengthen North American market presence.

NJR Medical manufactures and distributes the No-Bite V™, a suction catheter introducer designed for oral airway management in critical care and respiratory therapy settings. The device prevents suction catheter-induced nasal trauma (SCINT) and associated complications including nasal bleeding, trauma, and MRSA colonization. The No-Bite V™ protocol provides an alternative to nasotracheal suctioning when contraindicated, particularly for patients on anticoagulation therapy, those with recent nasal/sinus surgery, head trauma, or other risk factors outlined in their "9 Nevers of Nasal Suctioning" clinical screening framework. The product is used across hospital acute care, home care, hospice, and palliative care settings to reduce sentinel events, hospital-acquired pneumonia, ventilator-associated pneumonia, and nosocomial infections. NJR Medical supports clinical adoption through in-service training videos, continuing education modules, policy templates, and published evidence in peer-reviewed respiratory therapy literature.

INTCO Medical Technology Co., Ltd. is a publicly listed (Shenzhen Stock Exchange: 300677) global manufacturer specializing in medical consumables, rehabilitation equipment, and physical therapy solutions. Headquartered in Zibo, Shandong, China, with production facilities across China and Vietnam, INTCO is the world's largest manufacturer of latex-free disposable gloves, with annual production capacity exceeding 103 billion units. The company serves over 15,000 customers across 150+ countries with a diversified product portfolio including nitrile gloves, vinyl gloves, synthetic latex gloves, surgical gowns, face masks, infection control products, ECG electrodes, ESU accessories, wheelchairs, mobility aids, hot/cold therapy products, and personal care items. Operating with 10+ production facilities and 10,000+ employees, INTCO emphasizes quality (ISO 13485, FDA 510(K), CE certification) and sustainability while maintaining regional offices across North America, Latin America, Europe, Asia, Africa, and Oceania.

Med Way Inc. (MedWay Group) is a global provider of innovative wound care products and clinical best practices, founded in 2008 and headquartered in the Greater Atlanta area. The company employs approximately 74 staff members, including clinicians and engineers. MedWay specializes in advanced wound care dressings—including collagens, alginates, hydrocolloids, foams, silicone foams, and antimicrobial dressings—as well as nano silver wound care solutions and alternating pressure low air loss mattress systems. These products are designed to accelerate wound healing, reduce supply costs, simplify application protocols, and improve caregiver efficiency. MedWay serves extended care facilities, home care providers, hospitals, and healthcare systems worldwide, offering customized support services and educational tools developed collaboratively with healthcare professionals to optimize supply chain management and clinical outcomes.

Serim Research Corporation is a manufacturer of specialty diagnostic test strips founded in 1988. The company specializes in FDA-cleared rapid testing solutions for dialysis centers, hospitals, surgery centers, and food production facilities. Core product lines include GUARDIAN® test strips for dialysis water quality and disinfectant monitoring, DISINTEK™ strips for high-level disinfectant verification in endoscopy and sterile processing, PINNACLE™ strips for cleaning validation in central service departments, MONITOR™ strips for food safety and sanitization applications, and PyloriTek® rapid urease tests for H. pylori detection. The company also provides custom test strip development, contract manufacturing, and private label solutions serving multiple industries including healthcare, food production, and laundry disinfection.

NovaMedUSA, Inc. is a manufacturer and distributor of specialty medical products serving anesthesiology, cardiology, neonatology, and critical care markets. The company specializes in temperature monitoring solutions, including core body temperature probes, neonatal skin temperature sensors compatible with major incubator systems (GE/Ohmeda, Dräger, Atom Medical), and wireless temperature monitoring. Product lines include fiber optic laryngoscopes (PREMIER, standard, LED, and MRI-conditional variants) for intubation procedures, esophageal stethoscopes (LIFESOUND) for heart/breath sound monitoring, and conductive patient warming systems (KOALA for adults and KOALA Infant Warmer for neonates) designed to prevent perioperative hypothermia. NovaMedUSA emphasizes energy-efficient, eco-friendly technology and SCIP-INF-10 compliant products. The company operates customer support Monday–Friday, 8:30 am–8:30 pm EST, with dedicated channels for current customers, prospective buyers, and dealer partners.

Mindset Medical is a digital health technology company that delivers an intelligent virtual health platform enabling intake, patient assessments, triage, and virtual exams through smartphone-based contactless video vital sign measurement. The platform uses patented remote photoplethysmography (rPPG) technology to transform standard device cameras into non-contact vital sign sensors, measuring heart rate, respiratory rate, and other physiological parameters without requiring traditional measurement devices or wearables. The solution includes real-time remote patient monitoring, precision health analytics, and API integration capabilities for seamless deployment across digital health ecosystems. Core features include edge-processing for privacy (video analysis occurs on-device with no transmission), end-to-end encryption, and FDA-cleared respiratory rate measurement functionality. Ideal for telehealth platforms, chronic disease management, post-acute care coordination, and integrated care delivery requiring continuous remote patient monitoring without hardware burden.

Etiometry, Inc. is a Boston-based medical technology company specializing in AI-driven clinical decision-support software for intensive care units (ICUs). The Etiometry Platform (T3 Platform) aggregates real-time patient data from bedside monitors, peripheral devices, and EHR systems into a unified dashboard powered by Bayesian models and proprietary AI algorithms. The platform computes personalized risk indices to enable proactive care management in both pediatric and adult critical care settings. Core features include data aggregation and visualization, risk analytics for hemodynamic and respiratory management, automated clinical pathway workflows aligned with hospital protocols, and quality improvement analytics. The platform has received 11 FDA 510(k) clearances and CE marking, and has been deployed across 150+ clinical studies leveraging 150+ million hours of de-identified patient data. Clinical evidence demonstrates up to 36% reduction in length of stay, 41% decrease in ICU readmissions, 30% reduction in mechanical ventilation time, and 29% shorter vasoactive infusion duration. Trusted by leading academic medical centers and top-ranked children's hospitals across North America, Europe, and Asia.

Ondine Biomedical Inc. is a Canadian life sciences company specializing in photodisinfection (antimicrobial photodynamic therapy) technologies for infection prevention and treatment. The company's patented platform uses non-thermal laser light activation with photosensitive agents to destroy bacteria, viruses, yeasts, fungi, and associated virulence factors within minutes—without generating antimicrobial resistance. The lead product, Steriwave, is a rapid nasal decolonization therapy that eliminates broad-spectrum pathogens including methicillin-resistant Staphylococcus aureus (MRSA), Candida auris, and SARS-CoV-2 from the nasal cavity, significantly reducing healthcare-associated infections (HAIs) and surgical site infections (SSIs). Clinical evidence from major Canadian hospitals demonstrates up to 84% reduction in postoperative infection rates and 39.5% pneumonia reduction in ICU settings. Photodisinfection offers advantages over traditional antibiotics including immediate pathogen destruction, potent anti-inflammatory effects, and safety for patient outcomes. The company maintains a pipeline of investigational products addressing chronic rhinosinusitis, burn and wound decolonization, endotracheal tube disinfection to prevent ventilator-associated pneumonia, and topical antiviral therapies for upper respiratory tract infections. Ondine's technology platform is designed for straightforward clinical adoption with minimal workflow disruption and no complex compliance barriers. Note: Products are not currently for sale in the United States. The company operates as a specialized biomedical device and therapeutic solutions provider focused on addressing antimicrobial resistance through innovative light-activated infection control mechanisms.

CenterPoint Systems LLC manufactures innovative medical devices and products serving the cardiovascular, respiratory, gastrointestinal, and critical care markets. Based in West Valley City, Utah, the company develops specialized equipment for acute and critical care settings, with a focus on supporting clinical outcomes in high-acuity patient populations. CenterPoint serves healthcare facilities through direct sales and customer support channels.

Vitaltec Corporation is a medical device manufacturer specializing in airway management and respiratory care products. The company develops and supplies closed suction systems, tracheostomy tubes (including subglottic suction variants), and oral care systems designed to prevent ventilator-associated pneumonia (VAP) and enhance infection control in intubated patients. Vitaltec's product portfolio includes proprietary brands: Vita-Cath, Rota-Trach, and Venti-Trach, each developed with patent-protected innovative designs and clinical input. The company emphasizes patient safety and comfort in all product design. Vitaltec maintains ISO 13485 certification, demonstrating compliance with international quality management standards for medical devices. The organization provides comprehensive clinical education resources on VAP prevention and respiratory care best practices to healthcare professionals. Products are marketed for ICU and critical care environments where infection prevention and patient monitoring are paramount. The company operates a global distribution and partnership model, positioning itself as a B2B supplier to hospitals, healthcare systems, and medical equipment distributors worldwide.

OralKleen is a Fall 2019 Arizona Innovation Challenge Award-winning medical device company specializing in comprehensive oral care solutions for hospitalized and ventilated patients. The company addresses the critical gap in oral hygiene delivery for incapacitated patients in ICU settings, with a primary focus on reducing Ventilator-Acquired Pneumonia (VAP)—a hospital-acquired infection affecting up to 50% of mechanically ventilated patients and resulting in 10–50% mortality among those infected. OralKleen's integrated system combines specialized oral care products with an innovative electric toothbrush featuring LED illumination and suctioning capability, enabling safe and efficient plaque removal while providing clear visibility for caregivers. Clinical studies demonstrate significant improvement across key oral health metrics (tongue, teeth, mucosa, and gingiva) and dramatic VAP rate reductions when comprehensive OralKleen care replaces standard protocols. The system delivers superior clinical outcomes at price parity with traditional, less effective methods, making it a cost-effective solution for hospital infection prevention programs.

N8 Medical LLC is a clinical-stage medical device company specializing in antimicrobial coating technology based on ceragenins—a novel class of active compounds that mimic innate immune system antimicrobial peptides. The company's lead product, CeraShield, is an antimicrobial coating applied to indwelling medical devices and implants to prevent hospital-acquired infections (HAIs) and biofilm formation. The flagship device is the CeraShield Endotracheal Tube (ETT), designed to prevent Ventilator-Associated Pneumonia (VAP), the most common and costly HAI in ICU settings with estimated global treatment costs exceeding $10 billion annually. The FDA has designated CeraShield ETT as a "Breakthrough Device" and it is cleared for routine clinical use in Canada, Colombia, Brazil, and the UAE, with FDA approval anticipated. N8 Medical's pipeline includes additional CeraShield-coated devices: an antimicrobial absorbable pacemaker envelope for prevention of cardiac implantable electronic device (CIED) infections, and coated pedicle screws for orthopedic implant-associated infection prevention. The company is also developing CeraShield-coated hemodialysis catheters. N8 Medical operates as part of N8 Biosciences holding company and maintains a pharmaceutical subsidiary, Kinnear Pharmaceuticals, advancing therapeutic drug development using ceragenins for cystic fibrosis and other conditions. The company has received multiple NIH SBIR grants and maintains partnerships with government agencies including USAMRIID for biodefense applications.

Kol Bio-Medical Instruments, Inc. is a medical device sales and distribution company specializing in direct sales representation, supply chain management, and go-to-market strategies for medical device manufacturers. The company operates as a strategic partner to device makers, providing clinically-oriented sales teams, market access, product revitalization services, and end-to-end warehousing and distribution capabilities. The company serves multiple hospital departments and procedural areas including interventional cardiology and radiology labs, operating rooms, critical care units, cardiac surgery programs, trauma centers, and neonatal intensive care units (NICU). Their expertise spans diagnostic and therapeutic devices used in acute care settings, life-support technologies, and specialized surgical equipment. Kol Bio-Medical combines direct sales representation with supply chain logistics, offering complete go-to-market planning, clinical education, inventory management, order fulfillment, and product tracking. The company employs representatives with clinical expertise who can educate healthcare providers on device applications and customer-level technical concepts. Core service offerings include growth strategy development, product line revitalization for mature devices, and comprehensive distribution from their Sterling, Virginia warehouse facility. The company does not manufacture devices but rather functions as a trusted distributor and sales partner for third-party medical device manufacturers seeking to expand market presence and revenue in hospital and acute care settings.

Daxor Corporation is a medical device company founded in 1970 and headquartered in Oak Ridge, Tennessee, specializing in blood volume measurement technology. The company's flagship product, the BVA-100 Blood Volume Analyzer, is an FDA-cleared diagnostic system that uses indicator dilution technique with I-131 Human Serum Albumin to provide precise quantification of total blood volume, plasma volume, and red cell mass in adult patients. The BVA-100 calculates normalized hematocrit and albumin transudation rate, enabling clinicians to detect hidden fluid imbalances that indirect measures miss. Daxor also supplies Volumex diagnostic kits, the radiopharmaceutical component required for blood volume analysis procedures. The technology is designed for hospital laboratory settings and clinical departments requiring critical fluid management decisions, including heart failure, critical care, sepsis, ARDS, syncope, and surgical blood loss assessment. The system is reimbursed by both public and private payers for inpatient and outpatient use, with demonstrated clinical outcomes in reducing mortality and hospital readmissions.

Transonic Systems Inc. is a medical device manufacturer specializing in ultrasonic Transit-Time blood flow measurement technologies. Founded in 1983 and headquartered in Ithaca, New York, the company provides precision measurement solutions for surgical, clinical, research, and OEM applications. Transonic's product portfolio includes intraoperative blood flow meters for cardiothoracic, cerebrovascular, transplant, and microvascular surgery; hemodialysis flow monitors for vascular access assessment; mechanical circulatory support flow measurement systems for ECMO and cardiopulmonary bypass; tubing flowsensors for biomedical research and device manufacturing; and comprehensive life science research instrumentation for blood flow, pressure, and cardiac output measurement. The company also offers Transonic-Inside™, a customizable OEM integration program enabling medical device developers to embed advanced flow measurement capabilities into their platforms. With global operations across the US, Europe, Asia, Japan, and Taiwan, Transonic serves hospitals, research institutions, and medical device manufacturers seeking gold-standard accuracy and validation-backed measurement solutions.

Sarnova HC, LLC is a holding company for a portfolio of healthcare distribution and services companies serving the emergency medical services (EMS), acute care, and hospital sectors. The company operates four primary brands: Bound Tree Medical, a national distributor of prehospital EMS supplies, equipment, and pharmaceuticals for first responders and paramedics; Tri-anim Health Services, providing respiratory, anesthesia, and critical care products to hospitals and health systems; Cardio Partners, specializing in automated external defibrillators (AED), sales, repair services, program management, and CPR training for sudden cardiac arrest prevention; and Digitech, a cloud-based billing and technology platform serving the EMS transport industry. Collectively, Sarnova and its subsidiaries distribute more than 100,000 health and safety products to thousands of providers across emergency care, hospitals, advanced patient-care facilities, schools, universities, businesses, and federal government agencies. The company has nearly 50 years of operational history and serves approximately 32,000 customers nationwide. Sarnova is owned by Patricia Industries, part of Investor AB. The company emphasizes clinical expertise, in-service training, and comprehensive support across the continuum of care.

Prenosis Inc. is a Chicago-based precision medicine and artificial intelligence company founded in 2014, specializing in AI-powered diagnostics for acute care settings. The company's flagship product, the Sepsis ImmunoScore™, is the first FDA De Novo-authorized AI diagnostic tool for sepsis diagnosis and prediction of adverse outcomes. It integrates seamlessly into hospital electronic medical records and provides real-time clinical decision support by combining biomarker analysis with clinical data. The proprietary Immunix® precision medicine platform captures extensive biomarker and clinical data from acute care patients, enabling the development and real-time deployment of precision medicine tools. This platform has built the world's largest biobank linked to clinical infection data in acute care, encompassing over 138,000 longitudinal specimens and 35,000 patients across 11+ hospitals. Prenosis partners with Roche Diagnostics for distribution through the navify® Algorithm Suite. The company empowers clinicians to move beyond symptom-based diagnoses toward biology-based treatment decisions, improving patient outcomes and reducing hospital costs while supporting quality metrics.

Kreg Therapeutics is a specialty hospital bed provider focused on therapeutic solutions for complex ICU and acute care patients. The company designs and manufactures specialty beds in the USA, including the Catalyst® Critical Recovery Bed featuring proprietary In-Bed Verticalization™ technology, which enables clinicians to safely position high-acuity patients upright while bedridden. This therapeutic approach accelerates mobilization and recovery for complex patients with conditions including organ transplant, burn injuries, ECMO support, and ventilator dependence. Kreg also offers bariatric beds (E-Z Wider®), acute care low beds, pressure injury management mattresses, and ancillary patient handling accessories. The company operates a high-touch service model with owned regional service centers, providing on-site product delivery, setup, staff training, and 24/7 support. Kreg serves over 350,000 patients annually across US hospitals, with particular adoption among trauma centers and critical care facilities seeking to improve patient outcomes, reduce length of stay, and enhance clinician safety during complex patient handling.

Guldmann North America is a specialized provider of safe patient handling and mobility solutions for healthcare environments. Founded in 1980 and headquartered in Tampa, Florida with offices in Medford, Massachusetts, the company delivers ceiling hoists, mobile lifters, patient slings, and comprehensive accessories designed for emergency care, intensive care, operating rooms, rehabilitation, and long-term care settings. Guldmann emphasizes early mobilization protocols that improve patient recovery outcomes while reducing caregiver injury risk through ergonomic design. Beyond equipment, the company offers integrated services including project consultancy, installation, training in safe patient handling techniques, and on-site support. With a global distributor network spanning Iceland to Australia and substantial service capabilities, Guldmann positions itself as one of the world's largest providers of ceiling hoist system installation and maintenance, serving hospitals, care facilities, and home care environments.

Mercury Medical is a specialty healthcare manufacturer and distributor headquartered in Clearwater, Florida, with over 60 years of operational history since 1963. The company designs, manufactures, and distributes innovative medical devices for critical care environments, with primary focus on emergency, anesthesia, respiratory, and neonatal markets. Mercury Medical's product portfolio includes airway management devices, resuscitators, CPAP systems, T-piece infant resuscitators, bag-valve-mask devices, video laryngoscopes, hemostatic gauze, and CO2 absorbent solutions. The organization provides comprehensive customer support including training seminars, virtual product demonstrations, and equipment maintenance services to hospital systems and healthcare facilities. Mercury Medical also operates as an OEM partner and maintains distribution agreements with regional healthcare networks and procurement groups such as HealthTrust Performance Group.

Medovate Limited is a UK-based medical device development and commercialization company specializing in bringing novel clinical innovations to market through structured partnerships with NHS clinicians and healthcare providers. The company operates across the full medical device development pipeline—from initial concept evaluation and clinical development through regulatory approval and global market launch. Medovate's current product portfolio includes Safira® (regional anesthesia injection safety system with automatic pressure limiting to reduce nerve injury risk), Glucosave® (critical care blood sampling safety device to prevent inappropriate insulin administration), Humidicare® (heat and moisture exchanger with visual alerts for mechanical ventilation circuits), LUMEVAC™ (endoscopic surgical device for management of life-threatening gastrointestinal tract infections), and CamPROBE (transperineal prostate biopsy facilitation device). The company leverages deep relationships with NHS institutions to validate medical needs, conduct clinical trials, and accelerate adoption of approved technologies. Medovate focuses on patient safety innovations and clinician-centered design, with demonstrated capability in securing regulatory clearance and driving market entry across multiple therapeutic domains including anesthesia, critical care, endoscopic surgery, and urology. The firm's model emphasizes unmet clinical needs resolution and cost-effective solutions for healthcare systems globally.

AirICU Inc. manufactures and distributes aerosol drug delivery systems for acute care and intensive care unit (ICU) environments. The company's primary product line focuses on nebulization solutions for critical care applications. AirICU Max+ is a medical mesh nebulizer designed for hospital and acute care settings, delivering aerosolized medications to critically ill patients. The company positions itself as a provider of full-scenario nebulization support for critical care facilities. Products are designed for use in ventilated and non-ventilated patient populations in ICU environments. The company serves hospital acute care departments and critical care units. No specific FDA clearance, ISO, or regulatory certifications are mentioned on the fetched website content, though such approvals would be expected for ICU medical devices distributed in the US market.

AccuVein is a medical device manufacturer specializing in near-infrared (NIR) vein visualization technology for vascular access procedures. The company develops handheld vein finder devices that enable healthcare professionals to visualize peripheral veins, valves, and bifurcations not visible to the naked eye, improving peripheral IV catheter placement success rates and reducing procedure time and complications. AccuVein's primary products serve acute care settings (emergency departments, ICUs, general wards), non-acute care environments (outpatient clinics, home care), and aesthetic/cosmetic medicine practices. Clinical evidence supports the technology with 92% first-attempt success rates for IV placement, 78% reduction in procedure time, 45% decrease in escalation calls, and 39% reduction in patient pain. The company manufactures multiple generations of vein visualization devices, including the AV500, AV600 (fourth-generation model recently launched), and associated accessories such as the HF580 Powered Stand for hands-free mobile applications. AccuVein's devices are recommended by leading professional societies for pre-insertion vascular assessment and are positioned to improve clinical outcomes, operational efficiency, staff well-being, and healthcare equity by enabling successful venous access across diverse patient populations.

Ondal Medical Systems GmbH is a global manufacturer of suspension arm systems and medical pendant carrier systems for hospitals, operating rooms, intensive care units, and diagnostic imaging areas. Founded in 1945 and headquartered in Hünfeld, Germany, the company operates as a B2B supplier specializing in customized ODM/OEM solutions for hospital suppliers and medical technology companies. With over 3 million suspension arms installed in approximately 70% of hospitals worldwide, Ondal designs and manufactures medical device suspension systems, surgical light positioning systems, medical display mounting solutions, and ceiling-mounted supply units. The company holds CE and UL certifications and complies with ISO 13485 medical device standards. Ondal provides comprehensive services including installation, maintenance, repairs, technical support, and product training through a dedicated Technical Service Department. Their solutions optimize workflow efficiency and ergonomics across operating rooms, radiology departments, examination rooms, and ICU environments.

ExThera Medical Corporation develops and commercializes the Seraph® 100 Microbind® Affinity Blood Filter, a single-use, extracorporeal blood filtration device designed to reduce pathogen levels in the bloodstream for patients with life-threatening bloodstream infections, sepsis, and related critical care conditions. The Seraph 100 employs proprietary microbead adsorption media with chemically-bonded modified heparin to selectively bind and remove pathogens—including bacteria, viruses, and endotoxins—from circulating blood while leaving the blood itself intact in the filter. The technology has been studied for COVID-19 treatment and is now advancing into clinical trials for broader infectious disease applications and oncology-related conditions through pipeline programs including ONCObind®. The company is advancing Phase I clinical trials (OSCAR I) for bloodstream infection management and exploring applications in pancreatic cancer treatment. ExThera's extracorporeal blood purification approach addresses a critical unmet need in intensive care settings where pathogenic load reduction can improve outcomes in sepsis, severe infections, and related hemodynamic compromise. The company maintains regulatory development pathways and publishes peer-reviewed clinical and preclinical data. Manufacturing and quality systems support single-use, sterile device production for hospital and critical care deployment.

NeVap Inc manufactures airway management devices focused on infection prevention and critical care outcomes. The company's flagship product is the Aspire Subglottic Endotracheal Tube (ASSET), a subglottic suction breathing tube engineered with a tissue spacer and multiple drainage ports to prevent tissue blockage during suctioning. The ASSET is designed to reduce ventilator-associated pneumonia (VAP), post-operative pneumonia, and aspiration pneumonia incidence by enabling effective subglottic drainage in ICU, operating room, and emergency department settings. Clinical evidence demonstrates that subglottic drainage reduces mechanical ventilation duration, pneumonia incidence, antibiotic consumption, and mortality in long-term ventilated patients. The device is supported by recommendations from the CDC, AHRQ, ATS, SHEA, APIC, IDSA, and AACN. NeVap's leadership includes medical device executives and FDA compliance experts, with an advisory board composed of life sciences professionals. The company is positioned to serve hospitals and healthcare systems across the Bay Area and beyond, addressing a significant clinical need in airway management and infection prevention protocols.

D • R Burton Healthcare manufactures respiratory care and anesthesia devices founded by healthcare clinicians specializing in positive expiratory pressure (PEP) therapy and airway management. The company produces a portfolio of OPEP (Oscillating Positive Expiratory Pressure) and PAP (Positive Airway Pressure) devices designed to improve patient outcomes in respiratory therapy, reduce hospital readmissions, and decrease ICU length of stay. Product lines include vPEP® (oscillating OPEP therapy), iPEP® (volume-based incentive OPEP device with visual feedback), PocketPEP® (portable OPEP therapy), OxyPAP® and OxyJet® (PAP therapy systems), OxyBreath™ and OxyTrainer™ Advantage (respiratory muscle training devices), and J-Wand airway management intubation systems. The company emphasizes clinician-guided design and value-driven innovation. Based in Farmville, NC, D • R Burton Healthcare serves acute care hospitals, rehabilitation facilities, and respiratory therapy clinics. Devices support post-operative recovery, prevention of respiratory complications, and management of chronic respiratory conditions. The iPEP® is specifically highlighted for reducing rehospitalizations through volume-based feedback that enables clinicians to verify adequate patient air intake during therapy.

Integrated Medical Systems, Inc. is a medical equipment distributor and service provider specializing in home infusion therapy, respiratory equipment, and enteral delivery devices. The company operates as a multi-service medical supplier offering rental, lease, and sales options for infusion pumps, IV poles, transfer devices, and wound care consumables under the IMed brand. Core business segments include equipment rentals tailored to treatment protocols and budget constraints; ISO-certified biomedical servicing and repair as a cost-effective alternative to in-house maintenance; asset management software (iQuest) providing real-time tracking and location monitoring of medical equipment; and cleanroom product consulting with USP 797 and USP 800-compliant supplies for controlled pharmacy environments. The company serves home infusion providers, healthcare facilities, and ambulatory care settings. Featured products include IMed EZ-FLOW infusion pumps (100mL and 270mL configurations at variable flow rates), IV poles (steel and disposable models), mini transfer pins, and elastic net tubular bandages in multiple sizes. The company maintains distribution operations and appears to serve national markets based on closure announcements for multiple locations. Services emphasize cost-effective equipment upkeep, regulatory compliance for compounded sterile preparations, and integrated asset visibility for hospital and infusion clinic operations.

Surgicure Technologies, Inc. is a medical device company specializing in airway management solutions for civilian and military healthcare applications. The company's flagship product, the HORSESHOE™, is a novel endotracheal (ET) tube securement device designed to address critical safety and comfort challenges in critical care settings. The HORSESHOE™ features a patented off-the-face horseshoe-shaped design with a robust locking mechanism, integrated molar props, and an adjustable track that accommodates ET tubes sized 6.5 to 10 mm. The device is engineered to eliminate medical device-related pressure injuries (MDRPIs) on the face by operating independent of facial skin or lip contact, eliminating the need for adhesives, tape, wires, or additional dressings that commonly cause pressure points and irritation. The HORSESHOE™ facilitates rapid ET tube repositioning via its smooth locking track, enabling assessment and cleaning of facial skin while maintaining airway security. Clinical applications include support for chemotherapy patients with TENS devices, patients with facial trauma, pressure injuries, burns, beards, and emaciated patients. The device supports essential VAP (ventilator-associated pneumonia) prevention practices per 2022 ICHE Guidelines and complies with International NPIAP MDRPI Prevention Guidelines. Surgicure is backed by prominent venture investors including Techstars, BakerBridge Capital, NSF Innovation Corps, and others. The company operates from Cambridge, Massachusetts, and is committed to reducing unplanned extubations, enhancing patient comfort, and standardizing ET tube stabilization practices across critical care environments.

SeaStar Medical is a clinical-stage immunotherapy company developing the Selective Cytopheretic Device (SCD), a patented therapeutic platform designed to treat destructive hyperinflammatory responses in critically ill patients. The SCD selectively targets and neutralizes highly activated neutrophils and monocytes responsible for cytokine storms—uncontrolled inflammatory cascades triggered by trauma, infection, or surgery that can lead to multiorgan failure and death in ICU settings. The device integrates seamlessly into existing hemodialysis delivery systems, offering a disease-modifying approach to restore immune balance without requiring standalone infrastructure. SeaStar's technology addresses a significant clinical gap: there are currently no FDA-approved therapeutic options specifically designed to calm hyperinflammation in this patient population. The company's clinical evidence supports that SCD therapy may reduce ICU length of stay, decrease dialysis dependency, and improve survival outcomes. The device is positioned for use in critical care and intensive care units treating sepsis, post-surgical complications, and trauma-induced inflammatory responses. SeaStar Medical is headquartered in Denver, Colorado, and is focused on advancing the critical-care treatment paradigm through robust scientific validation and regulatory pathways.

Pronia Medical Systems develops GlucoCare, an FDA-cleared insulin dosing calculator software designed for critical care settings. GlucoCare is a web-based medical device that runs on standard browsers within hospital intranets or via cloud deployment, requiring minimal IT infrastructure for installation. The system implements the Yale Protocol—a customized, patient-response-based insulin dosing algorithm that accounts for current blood glucose, prior glucose trends, measurement intervals, and current insulin rate to calculate real-time insulin resistance and recommend safe dose adjustments. Clinical evidence demonstrates GlucoCare achieves hypoglycemia rates below 0.2% for readings <70 mg/dL while maintaining target glucose ranges. The platform supports multiple protocol variants (GlucoCare-140, GlucoCare-160) with configurable target ranges (100–160 mg/dL) and allows clinician overrides with quality assurance documentation. Built-in analytics provide unit-level and individual-user tracking for glucose control compliance and protocol adherence, enabling continuous quality improvement. GlucoCare integrates with hospital EMR systems and has been validated in peer-reviewed literature (Diabetes, Technology and Therapeutics). The company partners with EHR platforms including Cerner-based systems. Intended users are primarily nurses and critical care teams in hospital ICU settings managing patients requiring insulin infusions.

CardioRenal Systems develops the RenalPro (RenalGuard outside the US) autonomously-controlled fluid management and therapeutic system designed to prevent acute kidney injury (AKI) across multiple clinical settings. RenalPro is an FDA-designated breakthrough device that responds to minute fluctuations in urine output while automatically adjusting IV fluid administration in 1 mL increments to maintain hemodynamic stability and prevent over- or under-hydration. The company's primary focus is cardiac surgery-associated AKI (CSA-AKI), where approximately 30% of patients suffer kidney injury post-operatively. In a randomized 220-patient UK study, RenalPro demonstrated a 52% reduction in AKI compared to standard care with no reported adverse events. The system also addresses contrast-associated AKI (CA-AKI) in catheterization lab procedures and shows potential for ICU-related AKI prevention in septic and critically ill patients. RenalPro integrates into existing clinical workflows and represents an alternative to traditional KDIGO bundle protocols, which demonstrate limited efficacy. The company holds ISO 13485 certification and FDA breakthrough device designation, positioning it as a specialized solution for kidney injury prevention in surgical and interventional cardiology settings.

Totex Manufacturing Inc. is a US-based designer and manufacturer of custom battery packs and charging systems serving medical, industrial, aerospace, and consumer markets since 1985 (35+ years of experience). The company provides comprehensive solutions from initial design through manufacturing, testing, and global logistics. In the medical sector, Totex supplies rechargeable batteries and chargers for portable diagnostic devices (ultrasound machines, blood pressure monitors, insulin pumps, portable monitors), portable medical equipment, and ICU/emergency devices requiring reliable power in demanding environments. The company manufactures to rigorous medical standards and maintains FDA registration. Core manufacturing capabilities include circuit design and PCB layout, fuel gauge and MCU firmware programming, in-house SMT assembly (7 fully automatic lines), plastic injection molding (27 machines), ultrasonic and spot welding, and automated cell sorting. Quality systems include ISO 9001, ISO 13485, and ISO 14001 certifications, with in-house UL2054 testing, Six Sigma training (1 master black belt, 2 black belts, 30+ green belts), and DPPMs typically <500 per year. Environmental testing capabilities in-house include temperature cycling, thermal shock, humidity, IP68 dust/water intrusion, vibration, drop, shock, and nail penetration testing. The company operates two manufacturing facilities (Torrance, California: 55,000 sq. ft.; Huizhou, China: 120,000 sq. ft.) with vertical integration enabling cost-effective and consistent production. Expertise spans all major cell chemistries: Li-Ion, LiFePO4, NiMH, Li-SOCl2. Logistics support includes ~98% on-time delivery, Kanban/VMI/consignment programs, and specialized handling of lithium-ion battery shipping regulations. Designs include autoclave and intrinsically safe ratings for medical applications.

Recovery Force Health develops innovative wearable medical devices and digital health solutions focused on early mobilization, deep vein thrombosis (DVT) prevention, and hospital-acquired pressure injury (HAPI) prevention. Founded in 2018 and based in Fishers, Indiana, the company specializes in data-driven therapeutic compression and patient positioning technologies for acute care hospital and home settings. Core product portfolio includes MAC™ (Movement and Compression), a wearable therapeutic compression device that measures and displays real-time patient compliance and mobility data; ELEVATE™, a patient positioner designed to offload the sacrum while enhancing comfort and compliance; and HeelP.O.D.™, a foot offloading device with immersion and envelopment technology for visual assurance of pressure relief. All devices integrate clinical data capture to support workflow optimization and patient outcomes tracking. The company has established clinical partnerships with Mayo Clinic since 2018 to develop wearable medical-tech garments. Recovery Force Health emphasizes evidence-based design: studies demonstrate that early progressive mobilization—including periodic positioning changes, transfers, and ambulation—is associated with improved functional recovery, reduced hospital costs, and shorter length of stay. The company has received industry recognition including Stevie Awards, Edison Awards (Bronze), TechPoint MIRA recognition, and HealthTech Top 100 designation. Recent press releases indicate significant revenue growth (threefold increase through 2025) and expanded market adoption across hospital systems. Products address clinical needs in acute care ICU, post-operative, and extended care settings where DVT and pressure injury prevention are critical quality and cost drivers. Recovery Force Health targets hospital systems, health networks, and home care providers seeking to improve patient mobility outcomes and reduce preventable complications.

LeviSense Medical develops an advanced instrumented bed system designed to prevent and treat pressure injuries (pressure ulcers/bed sores) through high-resolution sensing and automated surface control. The LeviSense Pro-Daptive™ SensorCell™ Flotation Surface continuously scans patient form, position, and movement multiple times per second, automatically adjusting the support surface to redistribute pressure and protect vulnerable areas without requiring caregiver intervention. The system features 16 programmable sections for patient-specific customization, Dynamic Offloading™ for automated pressure relief, and Heel Flotation™ for targeted protection. Key benefits include reduced nursing labor demands, decreased repositioning-related injury risk to patients and caregivers, and enhanced patient comfort through advanced envelopment technology. Compatible with standard hospital and home bed frames, the system integrates remote monitoring capabilities and is designed for seamless deployment across ICU through home-care settings, supporting institutional and home-based care delivery models.

Patient Safety Systems Inc manufactures fall prevention and therapeutic support systems for healthcare facilities. The company specializes in safety covers and pressure relief mattresses designed to reduce patient fall risk and provide comfort during therapy and recovery. Their product portfolio includes the Safe & Secure Safety Cover line (5 different styles) and Flotation Air mattress systems with optional heel-off technology. All Flotation Air and Flotation Air Plus mattresses are supplied with integrated Safe & Secure Safety Covers. These systems employ pneumatic flotation technology with whisper-quiet pumps to support pressure management and patient positioning. The company serves acute care hospitals, rehabilitation centers, and long-term care facilities, positioning itself as a specialty support and fall prevention provider. Products are clinically proven and designed for diverse patient needs ranging from standard to complex care requirements.

BrainSpace develops automated cerebrospinal fluid (CSF) management systems for acute care settings. The company's flagship product, the Intellidrop, automates external ventricular drainage (EVD) and lumbar drain management at the bedside, replacing labor-intensive manual monitoring with robotic precision and closed-loop automation. The Intellidrop features a wearable transducer that eliminates the need for manual leveling or zeroing, reducing nursing workload while improving patient experience and clinical outcomes. The system combines continuous sensing and gravity-based drainage principles trusted by neurosurgeons, enabling single-drop drainage control with personalized pressure or volume targets for each patient. The device generates high-frequency multimodal data that can be autonomously annotated in real-time, supporting research and AI training without manual data cleaning. BrainSpace's technology addresses CSF management for acute conditions including traumatic brain injury (TBI), hemorrhagic stroke, meningitis, post-neurosurgical care, and diagnostic evaluation for normal pressure hydrocephalus (NPH). The company targets ICU settings where improved automation is expected to support patient mobilization, reduce length of stay, alleviate nursing staffing challenges, and expand access to critical CSF management.

BPB MEDICA is an Italian-based medical device manufacturer specializing in minimally invasive surgical instruments and devices. The company operates fully integrated in-house production capabilities and serves multiple clinical specialties including spine surgery, orthopedic biologics, assisted reproduction technology, aesthetic procedures, and intensive care applications. Product lines encompass biopsy instrumentation, spinal surgical tools, orthobiologic delivery systems, and reproductive medicine devices. The manufacturer emphasizes precision engineering and innovation in minimally invasive techniques to improve patient outcomes and surgical efficiency. The company actively participates in major international medical conferences including MEDICA, EUROSPINE, Global Spine Congress, ESHRE, and NASS, indicating strong market presence in Europe and North America. BPB MEDICA demonstrates commitment to regulatory compliance and patient safety standards, including adherence to EU Medical Device Regulation requirements. The organization offers hands-on clinical training through initiatives such as the Verona Pain Academy to advance practitioner knowledge in regenerative techniques and osteoarthritis management.

Summit International Medical Technologies is a specialty medical device manufacturer focused on critical care, anesthesia, dialysis, and neonatal markets. The company develops, manufactures, and distributes clinically innovative disposable and durable medical products designed to enhance patient safety and clinician efficiency while providing cost-effective care solutions. Key product lines include: Covalon AquaGuard moisture barrier systems for IV sites, PICC lines, and wound dressings; Parasol Medical fall prevention systems (wired and wireless) and DrySmart incontinence management pads; Starboard Medical temperature management probes for patient monitoring; Summit Medical AngelTip Safety Fistula for dialysis access; SternaSafe Uni sternum support braces for post-sternotomy recovery and SternaBra for women; Parasol Medical Cultivate quality assurance products for aseptic procedures; and NDI disposable marking spheres for surgical navigation and tracking. The company also acquired the Critical Concepts Inc. neonatal distribution product line in 2020, expanding its NICU offerings. Summit operates primarily in the United States, serving hospitals, critical care units, dialysis centers, and surgical facilities. The company emphasizes clinician-trusted, easy-to-use solutions with measurable clinical outcomes such as reduced complications, faster patient recovery, and improved safety. Products are designed for both acute hospital settings and post-operative care environments.

CoapTech manufactures the PUMA-G System, the FDA-cleared ultrasound-guided percutaneous gastrostomy (PUG) solution for bedside feeding tube placement in critical care and acute care settings. The system enables physicians and advanced practice providers to perform gastrostomy procedures at the patient bedside using ultrasound visualization, eliminating the need for operating room scheduling, endoscopic reprocessing, or fluoroscopy exposure. Clinical evidence demonstrates significant hospital cost reductions (up to $34,778 per patient) and shortened ICU length of stay (5–10 days) compared to traditional PEG or PRG procedures. The PUMA-G System is deployed in ICUs, step-down units, floor units, interventional radiology suites, and long-term acute care hospitals. The system reduces procedural risks including organ perforation from blind sticks, infection from endoscope reprocessing, and radiation exposure from fluoroscopy. Key clinical applications include COVID-19 patient care (tandem tracheostomy–gastrostomy procedures) and integration into critical care teams to optimize patient throughput and procedural efficiency. CoapTech holds FDA 510(k) clearance and serves tertiary care centers, academic medical centers, community hospitals, and for-profit hospital systems across the United States.